Sarah M Bhagat - Net Worth and Insider Trading
Sarah M Bhagat Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sarah M Bhagat owns 1 companies in total, including Inozyme Pharma Inc (INZY) .
Click here to see the complete history of Sarah M Bhagat’s form 4 insider trades.
Insider Ownership Summary of Sarah M Bhagat
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
INZY | Inozyme Pharma Inc | 2020-07-23 | director |
Sarah M Bhagat Trading Performance
Sarah M Bhagat Ownership Network
Ownership Network List of Sarah M Bhagat
Ownership Network Relation of Sarah M Bhagat
Sarah M Bhagat Owned Company Details
What does Inozyme Pharma Inc do?
Who are the key executives at Inozyme Pharma Inc?
Sarah M Bhagat is the director of Inozyme Pharma Inc. Other key executives at Inozyme Pharma Inc include director & 10 percent owner Robert Lorne Hopfner , COO Matthew Winton , and See Remarks Henric Bjorn Bjarke .
Inozyme Pharma Inc (INZY) Insider Trades Summary
Over the past 18 months, Sarah M Bhagat made no insider transaction in Inozyme Pharma Inc (INZY). Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net purchase of 833,333 shares made by Pivotal Bioventure Partners Fund I G.p., L.p. , a net purchase of 833,333 shares made by Robert Lorne Hopfner , and a net sale of 7,523 shares made by Douglas A Treco .
In summary, during the past 3 months, insiders sold 0 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,523 shares of Inozyme Pharma Inc (INZY) were sold and 1,666,666 shares were bought by its insiders, resulting in a net purchase of 1,659,143 shares.
Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inozyme Pharma Inc Insider Transactions
Sarah M Bhagat Mailing Address
Above is the net worth, insider trading, and ownership report for Sarah M Bhagat. You might contact Sarah M Bhagat via mailing address: C/o Inozyme Pharma, Inc., 321 Summer Street, Suite 400, Boston Ma 02210.